Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae

References

• Van Eldere J, Slack MP, Ladhani S, et al. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis. 2014;14(12):1281–1292.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Murphy TF. Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. J Clin Microbiol. 2011;49(11):3728–3732.
   PubMed Web of Science ®Google Scholar
• Brook I. Current issues in the management of acute bacterial sinusitis in children. Int J Pediatr Otorhinolaryngol. 2007;71(11):1653–1661.
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev. 2001;14(2):336–363.
   PubMed Web of Science ®Google Scholar
• Langereis JD, de Jonge MI. Invasive disease caused by nontypeable Haemophilus influenzae. Emerg Infect Dis. 2015;21:10.
   Web of Science ®Google Scholar
• Giufre M, Daprai L, Cardines R, et al. Carriage of Haemophilus influenzae in the oropharynx of young children and molecular epidemiology of the isolates after fifteen years of H. influenzae type b vaccination in Italy. Vaccine. 2015;33(46):6227–6234.
   Web of Science ®Google Scholar
• Pichichero ME. Otitis media. Pediatr Clin North Am. 2013;60(2):391–407.
   PubMed Web of Science ®Google Scholar
• Pichichero ME. Antibiotics for acute otitis media: yes or no. JAMA. 2015;313(3):294–295.
   PubMed Web of Science ®Google Scholar
• Morris PS, Leach AJ. Acute and chronic otitis media. Pediatr Clin North Am. 2009;56(6):1383–1399.
   PubMedGoogle Scholar
• Pumarola F, Mares J, Losada I, et al. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era. Int J Pediatr Otorhinolaryngol. 2013;77(8):1231–1236.
   PubMed Web of Science ®Google Scholar
• Monasta L, Ronfani L, Marchetti F, et al. Burden of disease caused by otitis media: systematic review and global estimates. Plos One. 2012;7(4):e36226.
   PubMed Web of Science ®Google Scholar
• Emmett SD, Francis HW. The socioeconomic impact of hearing loss in U.S. adults. Otol Neurotol. 2015;36(3):545–550.
   PubMed Web of Science ®Google Scholar
• Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29(4):304–309.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, et al. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis. 2014;59(12):1724–1732.
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298(15):1772–1778.
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Casey JR, Hoberman A, et al. Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006. Clin Pediatr (Phila.). 2008;47(9):901–906.
   PubMed Web of Science ®Google Scholar
• Leibovitz E, Asher E, Piglansky L, et al. Is bilateral acute otitis media clinically different than unilateral acute otitis media? Pediatr Infect Dis J. 2007;26(7):589–592.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Faden H, Bakaletz LO, et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J. 2009;28(1):43–48.
   PubMed Web of Science ®Google Scholar
• Xu Q, Almudervar A, Casey JR, et al. Nasopharyngeal bacterial interactions in children. Emerg Infect Dis. 2012;18(11):1738–1745.
   PubMed Web of Science ®Google Scholar
• Ruohola A, Pettigrew MM, Lindholm L, et al. Bacterial and viral interactions within the nasopharynx contribute to the risk of acute otitis media. J Infect. 2013;66(3):247–254.
   PubMed Web of Science ®Google Scholar
• Clementi CF, Murphy TF. Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract. Front Cell Infect Microbiol. 2011;1:1.
   PubMed Web of Science ®Google Scholar
• Erwin AL, Smith AL. Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol. 2007;15(8):355–362.
   PubMed Web of Science ®Google Scholar
• Dawid S, Barenkamp SJ, St Geme JW 3rd. Variation in expression of the Haemophilus influenzae HMW adhesins: a prokaryotic system reminiscent of eukaryotes. Proc Natl Acad Sci U S A. 1999;96(3):1077–1082.
   PubMed Web of Science ®Google Scholar
• Garmendia J, Marti-Lliteras P, Moleres J, et al. Genotypic and phenotypic diversity of the noncapsulated Haemophilus influenzae: adaptation and pathogenesis in the human airways. Int Microbiol. 2012;15(4):159–172.
   PubMed Web of Science ®Google Scholar
• Rappuoli R. The vaccine containing recombinant pertussis toxin induces early and long-lasting protection. Biologicals. 1999;27(2):99–102.
   PubMed Web of Science ®Google Scholar
• Kraus W, Ohyama K, Snyder DS, et al. Autoimmune sequence of streptococcal M protein shared with the intermediate filament protein, vimentin. J Exp Med. 1989;169(2):481–492.
   PubMed Web of Science ®Google Scholar
• Forsgren A, Riesbeck K, Janson H. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines. Clin Infect Dis. 2008;46(5):726–731.
   PubMed Web of Science ®Google Scholar
• Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367(9512):740–748.
   PubMed Web of Science ®Google Scholar
• Boldt A, Borte S, Fricke S, et al. Eight color immunophenotyping of T-, B- and NK-cell subpopulations for characterization of chronic immunodeficiencies. Cytometry B Clin Cytom. 2014;86(3):191–206.
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Hoet B, Adegbola RA. Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough. Expert Rev Vaccines. 2015;14(3):413–428.
   PubMed Web of Science ®Google Scholar
• Silfverdal SA, Skerlikova H, Zanova M, et al. Anamnestic immune response in 3- to 4-year-old children previously immunized with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine as 2-dose or 3-dose priming and a booster dose in the first year of life. Pediatr Infect Dis J. 2011;30(9):e155–e163.
   PubMed Web of Science ®Google Scholar
• van den Bergh MR, Spijkerman J, Swinnen KM, et al. Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin Infect Dis. 2013;56(3):e30–e39.
   PubMed Web of Science ®Google Scholar
• Tregnaghi MW, Saez-Llorens X, Lopez P, et al. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial. PLoS Med. 2014;11(6):e1001657.
   PubMed Web of Science ®Google Scholar
• Berglund J, Vink P, Tavares Da Silva F, et al. Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults. Clin Vaccine Immunol: CVI. 2014;21(1):56–65.
   PubMed Web of Science ®Google Scholar
• Nelson MB, Murphy TF, van Keulen H, et al. Studies on P6, an important outer-membrane protein antigen of Haemophilus influenzae. Rev Infect Dis. 1988;10(Suppl. 2):S331–S336.
   PubMedGoogle Scholar
• Bogdan JA Jr., Apicella MA. Mapping of a surface-exposed, conformational epitope of the P6 protein of Haemophilus influenzae. Infect Immun. 1995;63(11):4395–4401.
   PubMed Web of Science ®Google Scholar
• De Chiara M, Hood D, Muzzi A, et al. Genome sequencing of disease and carriage isolates of nontypeable Haemophilus influenzae identifies discrete population structure. Proc Natl Acad Sci U S A. 2014;111(14):5439–5444.
   PubMed Web of Science ®Google Scholar
• Chang A, Kaur R, Michel LV, et al. Haemophilus influenzae vaccine candidate outer membrane protein P6 is not conserved in all strains. Hum Vaccin. 2011;7(1):102–105.
   PubMed Web of Science ®Google Scholar
• Michel LV, Snyder J, Schmidt R, et al. Dual orientation of the outer membrane lipoprotein P6 of nontypeable Haemophilus influenzae. J Bacteriol. 2013;195(14):3252–3259.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Kirkham C, Lesse AJ. Construction of a mutant and characterization of the role of the vaccine antigen P6 in outer membrane integrity of nontypeable Haemophilus influenzae. Infect Immun. 2006;74(9):5169–5176.
   PubMed Web of Science ®Google Scholar
• Harabuchi Y, Faden H, Yamanaka N, et al. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. Tonawanda/Williamsville Pediatrics. J Infect Dis. 1994;170(4):862–866.
   PubMed Web of Science ®Google Scholar
• Harabuchi Y, Faden H, Yamanaka N, et al. Human milk secretory IgA antibody to nontypeable Haemophilus influenzae: possible protective effects against nasopharyngeal colonization. J Pediatr. 1994;124(2):193–198.
   PubMed Web of Science ®Google Scholar
• Yamanaka N, Faden H. Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children. J Pediatr. 1993;122(2):212–218.
   PubMed Web of Science ®Google Scholar
• DeMaria TF, Murwin DM, Leake ER. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media. Infect Immun. 1996;64(12):5187–5192.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Bartos LC, Rice PA, et al. Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody. J Clin Invest. 1986;78(4):1020–1027.
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Kaur R, Casey JR, et al. Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 2010;28(44):7184–7192.
   PubMed Web of Science ®Google Scholar
• Kaur R, Casey JR, Pichichero ME. Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children. Vaccine. 2011;29(5):1023–1028.
   PubMed Web of Science ®Google Scholar
• Kyd JM, Cripps AW. Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model. Infect Immun. 1998;66(5):2272–2278.
   PubMed Web of Science ®Google Scholar
• El-Adhami W, Kyd JM, Bastin DA, et al. Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein. Infect Immun. 1999;67(4):1935–1942.
   PubMed Web of Science ®Google Scholar
• Kyd JM, Cripps AW, Novotny LA, et al. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx. Infect Immun. 2003;71(8):4691–4699.
   PubMed Web of Science ®Google Scholar
• Friedel V, Zilora S, Bogaard D, et al. Five-year prospective study of paediatric acute otitis media in Rochester, NY: modelling analysis of the risk of pneumococcal colonization in the nasopharynx and infection. Epidemiol Infect. 2014;142(10):2186–2194.
   PubMed Web of Science ®Google Scholar
• Kaur R, Casey JR, Pichichero ME. Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children. Pediatr Infect Dis J. 2011;30(8):645–650.
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Kaur R, Casey JR, et al. Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children. Hum Vaccin Immunother. 2012;8(6):799–805.
   PubMed Web of Science ®Google Scholar
• Friedel V, Chang A, Wills J, et al. Impact of respiratory viral infections on alpha-hemolytic streptococci and otopathogens in the nasopharynx of young children. Pediatr Infect Dis J. 2013;32(1):27–31.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Casey JR, Pichichero ME. Reduced memory CD4+ T-cell generation in the circulation of young children may contribute to the otitis-prone condition. J Infect Dis. 2011;204(4):645–653.
   PubMed Web of Science ®Google Scholar
• Verhoeven D, Xu Q, Pichichero ME. Differential impact of respiratory syncytial virus and parainfluenza virus on the frequency of acute otitis media is explained by lower adaptive and innate immune responses in otitis-prone children. Clin Infect Dis. 2014;59(3):376–383.
   PubMed Web of Science ®Google Scholar
• Casey JR, Pichichero ME. Payment analysis of two diagnosis and management approaches of acute otitis media. Clin Pediatr. 2014;53(9):865–873.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Roumanes D, Almudevar A, et al. CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens. Vaccine. 2013;31(30):3090–3097.
   PubMed Web of Science ®Google Scholar
• Yamanaka N, Hotomi M, Billal DS. Clinical bacteriology and immunology in acute otitis media in children. J Infect Chemother. 2008;14(3):180–187.
   PubMedGoogle Scholar
• Hotomi M, Yamanaka N, Saito T, et al. Antibody responses to the outer membrane protein P6 of non-typeable Haemophilus influenzae and pneumococcal capsular polysaccharides in otitis-prone children. Acta Otolaryngol. 1999;119(6):703–707.
   PubMed Web of Science ®Google Scholar
• Veenhoven R, Rijkers G, Schilder A, et al. Immunoglobulins in otitis-prone children. Pediatr Res. 2004;55(1):159–162.
   PubMed Web of Science ®Google Scholar
• Wiertsema SP, Sanders EA, Veenhoven RH, et al. Antibody levels after regular childhood vaccinations in the immunological screening of children with recurrent otitis media. J Clin Immunol. 2004;24(4):354–360.
   PubMed Web of Science ®Google Scholar
• Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr. 2001;160(7):407–413.
   PubMed Web of Science ®Google Scholar
• Khan MN, Kaur R, Pichichero ME. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children. FEMS Immunol Med Microbiol. 2012;65(3):439–447.
   PubMedGoogle Scholar
• Sharma SK, Casey JR, Pichichero ME. Reduced serum IgG responses to pneumococcal antigens in otitis-prone children may be due to poor memory B-cell generation. J Infect Dis. 2012;205(8):1225–1229.
   PubMed Web of Science ®Google Scholar
• Avanzini AM, Castellazzi AM, Marconi M, et al. Children with recurrent otitis show defective IFN gamma-producing cells in adenoids. Pediatr Allergy Immunol. 2008;19(6):523–526.
   PubMed Web of Science ®Google Scholar
• Kodama H, Faden H, Harabuchi Y, et al. Adenoid lymphocyte responses to outer membrane protein P6 of nontypable Haemophilus influenzae in children with and without otitis media. Acta Otolaryngol Suppl. 1996;523:153–154.
   PubMedGoogle Scholar
• Kodama H, Faden H, Harabuchi Y, et al. Cellular immune response of adenoidal and tonsillar lymphocytes to the P6 outer membrane protein of non-typeable Haemophilus influenzae and its relation to otitis media. Acta Otolaryngol. 1999;119(3):377–383.
   PubMed Web of Science ®Google Scholar
• Kaminkova J, Lange CF. Transfer factor and repeated otitis media. Cell Immunol. 1984;89(1):259–264.
   PubMed Web of Science ®Google Scholar
• McMahon M, Murphy TF, Kyd J, et al. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity. Vaccine. 2005;23(27):3590–3596.
   PubMed Web of Science ®Google Scholar
• Kodama S, Suenaga S, Hirano T, et al. Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization. Infect Immun. 2000;68(4):2294–2300.
   PubMed Web of Science ®Google Scholar
• Noda K, Kodama S, Umemoto S, et al. Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx. Vaccine. 2010;28(31):5068–5074.
   PubMed Web of Science ®Google Scholar
• Noda K, Kodama S, Umemoto S, et al. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide. Microbiol Immunol. 2011;55(8):574–581.
   PubMed Web of Science ®Google Scholar
• Loosmore SM, Yang YP, Coleman DC, et al. Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease. Infect Immun. 1997;65(9):3701–3707.
   PubMed Web of Science ®Google Scholar
• Cutter D, Mason KW, Howell AP, et al. Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice. J Infect Dis. 2002;186(8):1115–1121.
   PubMed Web of Science ®Google Scholar
• Rodriguez CA, Avadhanula V, Buscher A, et al. Prevalence and distribution of adhesins in invasive non-type b encapsulated Haemophilus influenzae. Infect Immun. 2003;71(4):1635–1642.
   PubMed Web of Science ®Google Scholar
• Liu DF, Mason KW, Mastri M, et al. The C-terminal fragment of the internal 110-kilodalton passenger domain of the Hap protein of nontypeable Haemophilus influenzae is a potential vaccine candidate. Infect Immun. 2004;72(12):6961–6968.
   PubMed Web of Science ®Google Scholar
• Winter LE, Barenkamp SJ. Antibodies specific for the Hia adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activity. Clin Vaccine Immunol: CVI. 2009;16(7):1040–1046.
   PubMed Web of Science ®Google Scholar
• St Geme JW 3rd, Kumar VV, Cutter D, et al. Prevalence and distribution of the hmw and Hia genes and the HMW and Hia adhesins among genetically diverse strains of nontypeable Haemophilus influenzae. Infect Immun. 1998;66(1):364–368.
   PubMed Web of Science ®Google Scholar
• Winter LE, Barenkamp SJ. Construction and immunogenicity of recombinant adenovirus vaccines expressing the HMW1, HMW2, or Hia adhesion protein of nontypeable Haemophilus influenzae. Clin Vaccine Immunol: CVI. 2010;17(10):1567–1575.
   PubMed Web of Science ®Google Scholar
• Barenkamp SJ. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas. Infect Immun. 1996;64(4):1246–1251.
   PubMed Web of Science ®Google Scholar
• Winter LE, Barenkamp SJ. Antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae are opsonophagocytic for both homologous and heterologous strains. Clin Vaccine Immunol: CVI. 2006;13(12):1333–1342.
   PubMed Web of Science ®Google Scholar
• Giufre M, Muscillo M, Spigaglia P, et al. Conservation and diversity of HMW1 and HMW2 adhesin binding domains among invasive nontypeable Haemophilus influenzae isolates. Infect Immun. 2006;74(2):1161–1170.
   PubMed Web of Science ®Google Scholar
• Winter LE, Barenkamp SJ. Human antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activity. Infect Immun. 2003;71(12):6884–6891.
   PubMed Web of Science ®Google Scholar
• Loosmore SM, Yang YP, Oomen R, et al. The Haemophilus influenzae HtrA protein is a protective antigen. Infect Immun. 1998;66(3):899–906.
   PubMed Web of Science ®Google Scholar
• Zagursky RJ, Ooi P, Jones KF, et al. Identification of a Haemophilus influenzae 5ʹ-nucleotidase protein: cloning of the nucA gene and immunogenicity and characterization of the NucA protein. Infect Immun. 2000;68(5):2525–2534.
   PubMed Web of Science ®Google Scholar
• Deich RA, Anilionis A, Fulginiti J, et al. Antigenic conservation of the 15,000-dalton outer membrane lipoprotein PCP of Haemophilus influenzae and biologic activity of anti-PCP antisera. Infect Immun. 1990;58(10):3388–3393.
   PubMed Web of Science ®Google Scholar
• Green BA, Vazquez ME, Zlotnick GW, et al. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model. Infect Immun. 1993;61(5):1950–1957.
   PubMed Web of Science ®Google Scholar
• Novotny LA, Adams LD, Kang DR, et al. Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidates. Vaccine. 2009;28(1):279–289.
   PubMed Web of Science ®Google Scholar
• Jurcisek JA, Bookwalter JE, Baker BD, et al. The PilA protein of non-typeable Haemophilus influenzae plays a role in biofilm formation, adherence to epithelial cells and colonization of the mammalian upper respiratory tract. Mol Microbiol. 2007;65(5):1288–1299.
   PubMed Web of Science ®Google Scholar
• Bakaletz LO, Baker BD, Jurcisek JA, et al. Demonstration of type IV pilus expression and a twitching phenotype by Haemophilus influenzae. Infect Immun. 2005;73(3):1635–1643.
   PubMed Web of Science ®Google Scholar
• Akkoyunlu M, Ruan M, Forsgren A. Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains. Infect Immun. 1991;59(4):1231–1238.
   PubMed Web of Science ®Google Scholar
• Janson H, Ruan M, Forsgren A. Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains. Infect Immun. 1993;61(11):4546–4552.
   PubMed Web of Science ®Google Scholar
• Song XM, Forsgren A, Janson H. The gene encoding protein D (hpd) is highly conserved among Haemophilus influenzae type b and nontypeable strains. Infect Immun. 1995;63(2):696–699.
   PubMed Web of Science ®Google Scholar
• Bakaletz LO, Kennedy BJ, Novotny LA, et al. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection. Infect Immun. 1999;67(6):2746–2762.
   PubMed Web of Science ®Google Scholar
• Kennedy BJ, Novotny LA, Jurcisek JA, et al. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge. Infect Immun. 2000;68(5):2756–2765.
   PubMed Web of Science ®Google Scholar
• Singh B, Brant M, Kilian M, et al. Protein E of Haemophilus influenzae is a ubiquitous highly conserved adhesin. J Infect Dis. 2010;201(3):414–419.
   PubMed Web of Science ®Google Scholar
• Ronander E, Brant M, Eriksson E, et al. Nontypeable Haemophilus influenzae adhesin protein E: characterization and biological activity. J Infect Dis. 2009;199(4):522–531.
   PubMed Web of Science ®Google Scholar
• Singh B, Al-Jubair T, Morgelin M, et al. The unique structure of Haemophilus influenzae protein E reveals multiple binding sites for host factors. Infect Immun. 2013;81(3):801–814.
   PubMed Web of Science ®Google Scholar
• Jalalvand F, Su YC, Morgelin M, et al. Haemophilus influenzae protein F mediates binding to laminin and human pulmonary epithelial cells. J Infect Dis. 2013;207(5):803–813.
   PubMed Web of Science ®Google Scholar
• Su YC, Jalalvand F, Morgelin M, et al. Haemophilus influenzae acquires vitronectin via the ubiquitous protein F to subvert host innate immunity. Mol Microbiol. 2013;87(6):1245–1266.
   PubMed Web of Science ®Google Scholar
• Jalalvand F, Littorin N, Su YC, et al. Impact of immunization with protein F on pulmonary clearance of nontypeable Haemophilus influenzae. Vaccine. 2014;32(20):2261–2264.
   PubMed Web of Science ®Google Scholar
• Bolduc GR, Bouchet V, Jiang RZ, et al. Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach. Infect Immun. 2000;68(8):4505–4517.
   PubMed Web of Science ®Google Scholar
• Munson R Jr., Grass S. Purification, cloning, and sequence of outer membrane protein P1 of Haemophilus influenzae type b. Infect Immun. 1988;56(9):2235–2242.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Bartos LC. Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae. Infect Immun. 1988;56(10):2673–2679.
   PubMed Web of Science ®Google Scholar
• Sikkema DJ, Murphy TF. Molecular analysis of the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun. 1992;60(12):5204–5211.
   PubMed Web of Science ®Google Scholar
• Bell J, Grass S, Jeanteur D, et al. Diversity of the P2 protein among nontypeable Haemophilus influenzae isolates. Infect Immun. 1994;62(6):2639–2643.
   PubMed Web of Science ®Google Scholar
• Ostberg KL, Russell MW, Murphy TF. Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae. Mucosal Immunol. 2009;2(1):63–73.
   PubMed Web of Science ®Google Scholar
• Green BA, Farley JE, Quinn-Dey T, et al. The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-e serum and cloning and sequencing of the structural gene. Infect Immun. 1991;59(9):3191–3198.
   PubMed Web of Science ®Google Scholar
• Hotomi M, Ikeda Y, Suzumoto M, et al. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. Vaccine. 2005;23(10):1294–1300.
   PubMed Web of Science ®Google Scholar
• Mason KW, Zhu D, Scheuer CA, et al. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Vaccine. 2004;22(25–26):3449–3456.
   PubMed Web of Science ®Google Scholar
• Green BA, Baranyi E, Reilly TJ, et al. Certain site-directed, nonenzymatically active mutants of the Haemophilus influenzae P4 lipoprotein are able to elicit bactericidal antibodies. Infect Immun. 2005;73(7):4454–4457.
   PubMed Web of Science ®Google Scholar
• Bakaletz LO, Leake ER, Billy JM, et al. Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla. Vaccine. 1997;15(9):955–961.
   PubMed Web of Science ®Google Scholar
• Webb DC, Cripps AW. Secondary structure and molecular analysis of interstrain variability in the P5 outer-membrane protein of non-typable Haemophilus influenzae isolated from diverse anatomical sites. J Med Microbiol. 1998;47(12):1059–1067.
   PubMed Web of Science ®Google Scholar
• Webb DC, Cripps AW. A P5 peptide that is homologous to peptide 10 of OprF from Pseudomonas aeruginosa enhances clearance of nontypeable Haemophilus influenzae from acutely infected rat lung in the absence of detectable peptide-specific antibody. Infect Immun. 2000;68(1):377–381.
   PubMed Web of Science ®Google Scholar
• Novotny LA, Pichichero ME, Denoel PA, et al. Detection and characterization of pediatric serum antibody to the OMP P5-homologous adhesin of nontypeable Haemophilus influenzae during acute otitis media. Vaccine. 2002;20(29–30):3590–3597.
   PubMed Web of Science ®Google Scholar
• Nelson MB, Munson RS Jr., Apicella MA, et al. Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms. Infect Immun. 1991;59(8):2658–2663.
   PubMed Web of Science ®Google Scholar
• Gray-Owen SD, Loosmore S, Schryvers AB. Identification and characterization of genes encoding the human transferrin-binding proteins from Haemophilus influenzae. Infect Immun. 1995;63(4):1201–1210.
   PubMed Web of Science ®Google Scholar
• Webb DC, Cripps AW. Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung. Infect Immun. 1999;67(5):2138–2144.
   PubMed Web of Science ®Google Scholar
• Loosmore SM, Yang YP, Coleman DC, et al. Cloning and expression of the Haemophilus influenzae transferrin receptor genes. Mol Microbiol. 1996;19(3):575–586.
   PubMed Web of Science ®Google Scholar
• Gu XX, Tsai CM, Ueyama T, et al. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins. Infect Immun. 1996;64(10):4047–4053.
   PubMed Web of Science ®Google Scholar
• Morey P, Viadas C, Euba B, et al. Relative contributions of lipooligosaccharide inner and outer core modifications to nontypeable Haemophilus influenzae pathogenesis. Infect Immun. 2013;81(11):4100–4111.
   PubMed Web of Science ®Google Scholar
• Rahman MM, Gu XX, Tsai CM, et al. The structural heterogeneity of the lipooligosaccharide (LOS) expressed by pathogenic non-typeable Haemophilus influenzae strain NTHi 9274. Glycobiology. 1999;9(12):1371–1380.
   PubMed Web of Science ®Google Scholar
• Masoud H, Moxon ER, Martin A, et al. Structure of the variable and conserved lipopolysaccharide oligosaccharide epitopes expressed by Haemophilus influenzae serotype b strain Eagan. Biochemistry. 1997;36(8):2091–2103.
   PubMed Web of Science ®Google Scholar
• Gu XX, Sun J, Jin S, et al. Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas. Infect Immun. 1997;65(11):4488–4493.
   PubMed Web of Science ®Google Scholar
• Sun J, Chen J, Cheng Z, et al. Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model. Vaccine. 2000;18(13):1264–1272.
   PubMed Web of Science ®Google Scholar
• Gu XX, Rudy SF, Chu C, et al. Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae. Vaccine. 2003;21(17–18):2107–2114.
   PubMed Web of Science ®Google Scholar
• Barenkamp SJ, Bodor FF. Development of serum bactericidal activity following nontypable Haemophilus influenzae acute otitis media. Pediatr Infect Dis J. 1990;9(5):333–339.
   PubMed Web of Science ®Google Scholar
• Barenkamp SJ, Leininger E. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect Immun. 1992;60(4):1302–1313.
   PubMed Web of Science ®Google Scholar
• Barenkamp SJ, St Geme JW 3rd. Identification of a second family of high-molecular-weight adhesion proteins expressed by non-typable Haemophilus influenzae. Mol Microbiol. 1996;19(6):1215–1223.
   PubMed Web of Science ®Google Scholar
• Atack JM, Winter LE, Jurcisek JA, et al. Selection and counterselection of Hia expression reveals a key role for phase-variable expression of Hia in infection caused by nontypeable Haemophilus influenzae. J Infect Dis. 2015;212(4):645–653.
   PubMed Web of Science ®Google Scholar
• Winter LE, Barenkamp SJ. Naturally-acquired HMW1/HMW2-specific serum antibodies in adults and children mediate opsonophagocytic killing of nontypeable Haemophilus influenzae. Clin Vaccine Immunol: CVI. 2015;23(1):37–46.
   PubMed Web of Science ®Google Scholar
• Euba B, Moleres J, Viadas C, et al. Relative contribution of P5 and Hap surface proteins to nontypable Haemophilus influenzae interplay with the host upper and lower airways. PLoS One. 2015;10(4):e0123154.
   PubMed Web of Science ®Google Scholar
• Zimmerman SM, Michel F, Hogan RJ, et al. The autotransporter BpaB contributes to the virulence of Burkholderia mallei in an aerosol model of infection. Plos One. 2015;10(5):e0126437.
   PubMed Web of Science ®Google Scholar
• Mes TH, van Putten JP. Positively selected codons in immune-exposed loops of the vaccine candidate OMP-P1 of Haemophilus influenzae. J Mol Evol. 2007;64(4):411–422.
   PubMed Web of Science ®Google Scholar
• Tchoupa AK, Lichtenegger S, Reidl J, et al. Outer membrane protein P1 is the CEACAM-binding adhesin of Haemophilus influenzae. Mol Microbiol. 2015;98(3):440–455.
   PubMed Web of Science ®Google Scholar
• Roier S, Leitner DR, Iwashkiw J, et al. Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice. Plos One. 2012;7(8):e42664.
   PubMed Web of Science ®Google Scholar
• Neary JM, Yi K, Karalus RJ, et al. Antibodies to loop 6 of the P2 porin protein of nontypeable Haemophilus influenzae are bactericidal against multiple strains. Infect Immun. 2001;69(2):773–778.
   PubMed Web of Science ®Google Scholar
• Neary JM, Murphy TF. Antibodies directed at a conserved motif in loop 6 of outer membrane protein P2 of nontypeable Haemophilus influenzae recognize multiple strains in immunoassays. FEMS Immunol Med Microbiol. 2006;46(2):251–261.
   PubMedGoogle Scholar
• Morton DJ, Smith A, VanWagoner TM, et al. Lipoprotein e (P4) of Haemophilus influenzae: role in heme utilization and pathogenesis. Microbes Infect/Institut Pasteur. 2007;9(8):932–939.
   PubMed Web of Science ®Google Scholar
• Zakharian E, Reusch RN. Pore characteristics of nontypeable Haemophilus influenzae outer membrane protein P5 in planar lipid bilayers. Biophys J. 2006;91(9):3242–3248.
   PubMed Web of Science ®Google Scholar
• Hill DJ, Toleman MA, Evans DJ, et al. The variable P5 proteins of typeable and non-typeable Haemophilus influenzae target human CEACAM1. Mol Microbiol. 2001;39(4):850–862.
   PubMed Web of Science ®Google Scholar
• Duim B, Bowler LD, Eijk PP, et al. Molecular variation in the major outer membrane protein P5 gene of nonencapsulated Haemophilus influenzae during chronic infections. Infect Immun. 1997;65(4):1351–1356.
   PubMed Web of Science ®Google Scholar
• Sirakova T, Kolattukudy PE, Murwin D, et al. Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A. Infect Immun. 1994;62(5):2002–2020.
   PubMed Web of Science ®Google Scholar
• Bakaletz LO. Peptide and recombinant antigens for protection against bacterial middle ear infection. Vaccine. 2001;19(17–19):2323–2328.
   PubMed Web of Science ®Google Scholar
• Novotny LA, Jurcisek JA, Pichichero ME, et al. Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae. Infect Immun. 2000;68(4):2119–2128.
   PubMed Web of Science ®Google Scholar
• Novotny LA, Clements JD, Bakaletz LO. Therapeutic transcutaneous immunization with a band-aid vaccine resolves experimental otitis media. Clin Vaccine Immunol: CVI. 2015;22(8):867–874.
   PubMed Web of Science ®Google Scholar
• Schryvers AB, Stojiljkovic I. Iron acquisition systems in the pathogenic Neisseria. Mol Microbiol. 1999;32(6):1117–1123.
   PubMed Web of Science ®Google Scholar
• Flack FS, Loosmore S, Chong P, et al. The sequencing of the 80-kDa D15 protective surface antigen of Haemophilus influenzae. Gene. 1995;156(1):97–99.
   PubMed Web of Science ®Google Scholar
• Thomas WR, Callow MG, Dilworth RJ, et al. Expression in escherichia coli of a high-molecular-weight protective surface antigen found in nontypeable and type b Haemophilus influenzae. Infect Immun. 1990;58(6):1909–1913.
   PubMed Web of Science ®Google Scholar
• Yang Y, Thomas WR, Chong P, et al. A 20-kilodalton N-terminal fragment of the D15 protein contains a protective epitope(s) against Haemophilus influenzae type a and type b. Infect Immun. 1998;66(7):3349–3354.
   PubMed Web of Science ®Google Scholar
• Noinaj N, Kuszak AJ, Gumbart JC, et al. Structural insight into the biogenesis of beta-barrel membrane proteins. Nature. 2013;501(7467):385–390.
   PubMed Web of Science ®Google Scholar
• Luthra A, Anand A, Hawley KL, et al. A homology model reveals novel structural features and an immunodominant surface loop/opsonic target in the Treponema pallidum BamA ortholog TP_0326. J Bacteriol. 2015;197(11):1906–1920.
   PubMed Web of Science ®Google Scholar
• Alonso S, Willery E, Renauld-Mongenie G, et al. Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier. Infect Immun. 2005;73(7):4295–4301.
   PubMed Web of Science ®Google Scholar
• Weinstein D, Turkovski S, Kerry C, et al. Cloning and characterization of an Haemophilus influenzae Type b Adhesin. Gen Meet Am Soc Microbiol. 1992;92:26–30.
   Google Scholar
• Novotny LA, Adams LD, Kang DR, et al. Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidates. Vaccine. 2010;28(1):279–289.
   Web of Science ®Google Scholar
• Amela I, Cedano J, Querol E. Pathogen proteins eliciting antibodies do not share epitopes with host proteins: a bioinformatics approach. Plos One. 2007;2(6):e512.
   PubMed Web of Science ®Google Scholar
• Deich RA, Metcalf BJ, Finn CW, et al. Cloning of genes encoding a 15,000-dalton peptidoglycan-associated outer membrane lipoprotein and an antigenically related 15,000-dalton protein from Haemophilus influenzae. J Bacteriol. 1988;170(2):489–498.
   PubMed Web of Science ®Google Scholar
• Ronander E, Brant M, Janson H, et al. Identification of a novel Haemophilus influenzae protein important for adhesion to epithelial cells. Microbes Infect/Institut Pasteur. 2008;10(1):87–96.
   PubMed Web of Science ®Google Scholar
• Barthel D, Singh B, Riesbeck K, et al. Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity. J Immunol. 2012;188(1):379–385.
   PubMed Web of Science ®Google Scholar
• Campagnari AA, Gupta MR, Dudas KC, et al. Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect Immun. 1987;55(4):882–887.
   PubMed Web of Science ®Google Scholar
• Clark SE, Eichelberger KR, Weiser JN. Evasion of killing by human antibody and complement through multiple variations in the surface oligosaccharide of Haemophilus influenzae. Mol Microbiol. 2013;88(3):603–618.
   PubMed Web of Science ®Google Scholar
• Langereis JD, Weiser JN. Shielding of a lipooligosaccharide IgM epitope allows evasion of neutrophil-mediated killing of an invasive strain of nontypeable Haemophilus influenzae. MBio. 2014;5(4):e01478–e01414.
   PubMed Web of Science ®Google Scholar
• Tong HH, Blue LE, James MA, et al. Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun. 2000;68(8):4593–4597.
   PubMed Web of Science ®Google Scholar
• Hirano T, Hou Y, Jiao X, et al. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx. FEMS Immunol Med Microbiol. 2003;35(1):1–10.
   PubMedGoogle Scholar
• Hong W, Peng D, Rivera M, et al. Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models. Microbes Infect/Institut Pasteur. 2010;12(1):11–18.
   PubMed Web of Science ®Google Scholar
• Choi J, Nix EB, Gaultier GN, et al. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals. Vaccine. 2015;33(16):1941–1947.
   PubMed Web of Science ®Google Scholar
• Mandrell RE, McLaughlin R, Aba Kwaik Y, et al. Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated. Infect Immun. 1992;60(4):1322–1328.
   PubMed Web of Science ®Google Scholar
• Ketterer MR, Shao JQ, Hornick DB, et al. Infection of primary human bronchial epithelial cells by Haemophilus influenzae: macropinocytosis as a mechanism of airway epithelial cell entry. Infect Immun. 1999;67(8):4161–4170.
   PubMed Web of Science ®Google Scholar
• Carruthers MD, Tracy EN, Dickson AC, et al. Biological roles of nontypeable Haemophilus influenzae type IV pilus proteins encoded by the pil and com operons. J Bacteriol. 2012;194(8):1927–1933.
   PubMed Web of Science ®Google Scholar
• Hong W, Juneau RA, Pang B, et al. Survival of bacterial biofilms within neutrophil extracellular traps promotes nontypeable Haemophilus influenzae persistence in the chinchilla model for otitis media. J Innate Immun. 2009;1(3):215–224.
   PubMed Web of Science ®Google Scholar